Beijing Chunlizhengda Medical Instruments Co., Ltd.

SEHK:1858 Stock Report

Market Cap: HK$6.8b

Beijing Chunlizhengda Medical Instruments Future Growth

Future criteria checks 5/6

Beijing Chunlizhengda Medical Instruments is forecast to grow earnings and revenue by 24.7% and 24.8% per annum respectively. EPS is expected to grow by 23.5% per annum. Return on equity is forecast to be 12.3% in 3 years.

Key information

24.7%

Earnings growth rate

23.5%

EPS growth rate

Medical Equipment earnings growth31.5%
Revenue growth rate24.8%
Future return on equity12.3%
Analyst coverage

Low

Last updated12 Nov 2023

Recent future growth updates

Beijing Chunlizhengda Medical Instruments Co., Ltd. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Apr 01
Beijing Chunlizhengda Medical Instruments Co., Ltd. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Recent updates

Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Shareholders Might Be Looking For Exit

Jan 06
Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Shareholders Might Be Looking For Exit

Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Dec 06
Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Aug 31
Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Paint A Concerning Picture

Here's What's Concerning About Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns On Capital

Apr 11
Here's What's Concerning About Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns On Capital

Here's What To Make Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Decelerating Rates Of Return

Dec 05
Here's What To Make Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Decelerating Rates Of Return

Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Have Hit The Brakes

Apr 28
Returns On Capital At Beijing Chunlizhengda Medical Instruments (HKG:1858) Have Hit The Brakes

I Built A List Of Growing Companies And Beijing Chunlizhengda Medical Instruments (HKG:1858) Made The Cut

Dec 30
I Built A List Of Growing Companies And Beijing Chunlizhengda Medical Instruments (HKG:1858) Made The Cut

Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

Dec 06
Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

Is Now The Time To Put Beijing Chunlizhengda Medical Instruments (HKG:1858) On Your Watchlist?

Sep 24
Is Now The Time To Put Beijing Chunlizhengda Medical Instruments (HKG:1858) On Your Watchlist?

We Like Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns And Here's How They're Trending

Sep 06
We Like Beijing Chunlizhengda Medical Instruments' (HKG:1858) Returns And Here's How They're Trending

We Take A Look At Whether Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) CEO May Be Underpaid

Jun 15
We Take A Look At Whether Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) CEO May Be Underpaid

Here's Why We Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is Well Worth Watching

Jun 05
Here's Why We Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is Well Worth Watching

Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

May 09
Beijing Chunlizhengda Medical Instruments (HKG:1858) Could Become A Multi-Bagger

Beijing Chunlizhengda Medical Instruments Co., Ltd. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Apr 01
Beijing Chunlizhengda Medical Instruments Co., Ltd. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

What Type Of Shareholders Make Up Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Share Registry?

Feb 22
What Type Of Shareholders Make Up Beijing Chunlizhengda Medical Instruments Co., Ltd.'s (HKG:1858) Share Registry?

Beijing Chunlizhengda Medical Instruments (HKG:1858) Is Very Good At Capital Allocation

Feb 07
Beijing Chunlizhengda Medical Instruments (HKG:1858) Is Very Good At Capital Allocation

Here's Why I Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is An Interesting Stock

Jan 25
Here's Why I Think Beijing Chunlizhengda Medical Instruments (HKG:1858) Is An Interesting Stock

Estimating The Intrinsic Value Of Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Jan 10
Estimating The Intrinsic Value Of Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Did You Participate In Any Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Incredible 713% Return?

Dec 28
Did You Participate In Any Of Beijing Chunlizhengda Medical Instruments' (HKG:1858) Incredible 713% Return?

Should You Rely On Beijing Chunlizhengda Medical Instruments's (HKG:1858) Earnings Growth?

Dec 16
Should You Rely On Beijing Chunlizhengda Medical Instruments's (HKG:1858) Earnings Growth?

Declining Stock and Solid Fundamentals: Is The Market Wrong About Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)?

Dec 04
Declining Stock and Solid Fundamentals: Is The Market Wrong About Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)?

Here's What We Learned About The CEO Pay At Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Nov 21
Here's What We Learned About The CEO Pay At Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Earnings and Revenue Growth Forecasts

SEHK:1858 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,999458416N/A2
12/31/20241,576359269N/A2
12/31/20231,209278N/AN/AN/A
9/30/20231,234279129131N/A
6/30/20231,1712776784N/A
3/31/20231,191290-64-59N/A
12/31/20221,2023081641N/A
9/30/20221,150328-4330N/A
6/30/20221,197324-4964N/A
3/31/20221,139328-34134N/A
12/31/20211,108322-35165N/A
9/30/2021984287-10177N/A
6/30/20211,013322137256N/A
3/31/20211,007318227303N/A
12/31/2020938283237261N/A
9/30/2020913264173249N/A
6/30/2020887244109238N/A
3/31/202082621669191N/A
12/31/201985523799232N/A
9/30/201975820168161N/A
6/30/20196601643791N/A
3/31/201957913547100N/A
12/31/201849810656109N/A
9/30/20184449472111N/A
6/30/20183898387113N/A
3/31/20183457684102N/A
12/31/2017300688190N/A
9/30/201726165N/A86N/A
6/30/201722163N/A82N/A
3/31/201721563N/A73N/A
12/31/201620863N/A65N/A
9/30/201620155N/A46N/A
6/30/201619547N/A27N/A
3/31/201618643N/A13N/A
12/31/201517738N/A-1N/A
9/30/201517947N/A7N/A
6/30/201516344N/A-16N/A
3/31/201514941N/A4N/A
12/31/201413537N/A24N/A
9/30/201412937N/A40N/A
12/31/201311133N/A28N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1858's forecast earnings growth (24.7% per year) is above the savings rate (2%).

Earnings vs Market: 1858's earnings (24.7% per year) are forecast to grow faster than the Hong Kong market (12.6% per year).

High Growth Earnings: 1858's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1858's revenue (24.8% per year) is forecast to grow faster than the Hong Kong market (8% per year).

High Growth Revenue: 1858's revenue (24.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1858's Return on Equity is forecast to be low in 3 years time (12.3%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.